Pathogen-specific ctl therapy

Details Pathogen-specific ctl therapy Pathogen-specific ctl therapy

A - Human Necessities

61

K

A61K 39/00 (2006.01) A61K 35/14 (2006.01) A61K 35/18 (2006.01)

Patent

CA 2089488

2089488 9204462 PCTABS00011 Disclosed is a method for the treatment of a patient infected with an intracellular pathogen, involving administering to the patient an intracellular pathogen-specific, cytotoxic T lymphocyte-stimulatory antigen, or a preparation of the patient's lymphocytes enriched for intracellular pathogen-specific cytotoxic T lymphocytes.

Affiliated with

Also associated with

Rating

Pathogen-specific ctl therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pathogen-specific ctl therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pathogen-specific ctl therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1741294